[Usefulness of Sandomigran in treatment of migraine syndromes].
D000293:Adolescent; D000328:Adult; D001567:Benzocycloheptenes / Q000627:therapeutic use; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use; D013577:Syndrome; D013876:Thiophenes / Q000627:therapeutic use*
D001567:Benzocycloheptenes; D010880:Piperidines; D013876:Thiophenes
Przydatność preparatu Sandomigran w leczeniu zespołów migrenowych.